AUA Foundation joins AUA in response to the ACS updated prostate cancer screening guidelines

NewsGuard 100/100 Score

The American Urological Association (AUA) Foundation joins the AUA in its response to the American Cancer Society (ACS) updated prostate cancer screening guidelines highlighting the importance of shared decision-making between patients and physicians. Prostate cancer testing is not a clear cut issue, and we agree that such discussion is critical to getting men the most objective, fair and reasonable information available. However, the AUA Foundation believes the ACS recommendation that men at varying risk consider prostate-specific antigen (PSA) testing at different ages does not fully address the individualized approach required when testing men for prostate cancer and may cause significant confusion for patients.

The AUA Foundation believes that part of the opportunity to make an informed decision with all of the information available includes knowledge of a man's baseline PSA score.  As recent research indicates the prostate changes over time, such a baseline taken at age 40 before age-related PSA increases take place helps men and their physicians better understand possible future results after test-altering changes occur. We therefore stand behind the AUA's research-based Best Practice Statement on Prostate-Specific Antigen recommending all  men 40 and over to talk to their doctors about the risks and benefits of prostate cancer testing, including establishing a baseline PSA score and regular physical exams.

Prostate cancer testing is an individual decision that patients should make together with their doctor, and because every case is different, there is no single standard for treatment that applies to all men, nor should there be at this time. Not all prostate cancers require immediate treatment. But doctors and their patients cannot make an informed treatment decision, including the option for active surveillance, if they never know the cancer is there. Informed prostate cancer testing empowers patients and their doctors with the information to decide what options are right for them.

Source:

The American Urological Association (AUA) Foundation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough imaging method enhances precision in prostate cancer treatment